Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises CELLINK in connection with the acquisition of Ginolis
Mandate

Vinge advises CELLINK in connection with the acquisition of Ginolis

February 15, 2021 M&A Capital Markets and Public M&A Intellectual Property

Vinge has advised CELLINK AB (publ) in connection with the acquisition of all shares in Ginolis Oy. Ginolis conducts operations in relation to automated diagnostics and provides advanced robotic solutions to the medical- and diagnostics industries.

The purchase price on a cash and debt free basis amount to EUR 70 million. Forty per cent of the purchase price will be paid with newly issued class B shares in CELLINK, with the remainder in cash.

Vinge’s team mainly consisted of Anders Strid, Johanna Hamrefält (project manager M&A), Anna Maria Lagerqvist Gahm and Alexander Lindeberg (IP), Aleksandar Bajic (M&A), Martin Svanberg (W&I) in addition to Edin Agic (Capital Markets). Krogerus Attorneys acted as local counsel in Finland.

Related

Vinge has advised Skeptiva AB in connection with its financing round

 Skeptiva is developing the next generation of cybersecurity defenses against fraud. The company has developed an AI application that detects attacks and alerts users in real time.
March 11, 2026

Vinge has advised Main Capital in connection with the acquisition of Good Solutions Sweden AB

 Good Solutions Sweden AB (”Good Solutions”) provides software that helps factories identify and reduce production losses. The software converts data from machines and operators into insights that can be used to streamline production and increase profitability.
March 11, 2026

Vinge represents Studsvik AB (publ) in the acquisition of Kärnfull Next AB

 Vinge has represented Studsvik AB (publ) in connection with the acquisition of Kärnfull Next AB, a company developing methods for building small modular nuclear reactors.
March 10, 2026